ECHO Access Opioid Use Disorder Treatment Guideline Opioid Abuse and Addiction Management Protocol All Team Members: Patient Self-Management Education and Support Opioid abuse and addiction is a serious problem in the U

First Page		Document Content
Date: 2014-10-24 11:36:53 Chemistry Neurochemistry Morphinans Nervous system Opioid antagonists Euphoriants Alcohols Drug rehabilitation Buprenorphine Opioid use disorder Opioid Naltrexone		ECHO Access Opioid Use Disorder Treatment Guideline Opioid Abuse and Addiction Management Protocol All Team Members: Patient Self-Management Education and Support Opioid abuse and addiction is a serious problem in the U Add to Reading List Source URL: echo.unm.edu Download Document from Source Website File Size: 690,78 KB Share Document on Facebook

	Microsoft Word - VLD Packet.FINAL DocID: 1rubZ - View Document
	Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa DocID: 1rtjz - View Document
	TITAN PHARMACEUTICALS CORPORATE PRESENTATION SUNIL BHONSLE JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. NASDAQ:TTNP DocID: 1rsmr - View Document
	“Hokus-Pokus Palliative Care” Case Report Gabriela Popescu, MD, M.Sc. Palliative Care, FMH Internal Medicine Tumor Zentrum and Hirslanden Klinik Aarau DocID: 1rsfZ - View Document
	Sunil Bhonsle Mar 2015 Corporate Presentation DocID: 1rrwl - View Document